These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 875253)

  • 21. A golden age for Haemophilia treatment?
    Makris M; Hermans C
    Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma clearance rates of coagulation factors VIII and IX in factor-deficient individuals.
    Noe DA; Bell WR; Ness PM; Levin J
    Blood; 1986 Apr; 67(4):969-72. PubMed ID: 3082391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
    István L; Bariska I; Marton E
    Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapy for AHF and PTC hemophilia. II.
    Seeler RA
    IMJ Ill Med J; 1970 Jun; 137(6):598-602 passim. PubMed ID: 4393113
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in the care and treatment of children with hemophilia.
    Manco-Johnson MJ
    Adv Pediatr; 2010; 57(1):287-94. PubMed ID: 21056743
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergency room care for hemophiliac patients. Understanding and overcoming difficulties.
    J Fla Med Assoc; 1993 Apr; 80(4):250-4. PubMed ID: 8505616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
    Fukui H
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):866-74. PubMed ID: 1919201
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemophilia in childhood.
    McNeill GF; Schwartz E
    Pa Med; 1975 Jan; 78(1):51-3. PubMed ID: 1128902
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study].
    Wu RH; Wu XY; Zhang NN; Zhao L; Zhang JS; Zhen YZ; Peng Y
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):632-4. PubMed ID: 23906463
    [No Abstract]   [Full Text] [Related]  

  • 31. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 33. Pioneering therapeutic proteins in hemophilia care through innovative technologies.
    Pabinger-Fasching I; Négrier C
    Thromb Res; 2016 May; 141 Suppl 3():S1. PubMed ID: 27288062
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy for AHF and PTC hemophilia. I.
    Seeler RA
    IMJ Ill Med J; 1970 May; 137(5):518-21. PubMed ID: 4392774
    [No Abstract]   [Full Text] [Related]  

  • 35. [Odontological problems in patients with hemophilia].
    Giuliano L; Saracini A; Bertolotto C
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):145-58. PubMed ID: 6443703
    [No Abstract]   [Full Text] [Related]  

  • 36. The current approach to hemophilia.
    Morrison CJ
    J Maine Med Assoc; 1974 Sep; 65(9):205-6. PubMed ID: 4416140
    [No Abstract]   [Full Text] [Related]  

  • 37. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future characteristics of bypassing agents to improve care of hemophilia inhibitor patients: an economic and health-related quality of life perspective.
    Weatherall J; Barnes N; Brown C; Préaud E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):411-4. PubMed ID: 21831021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia in a Changing Treatment Landscape.
    Pelland-Marcotte MC; Carcao MD
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):409-423. PubMed ID: 31030810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for management of hemophilia A and B.
    Djulbegovic B; Goldsmith GH
    Blood; 1995 Jan; 85(2):598-9. PubMed ID: 7812015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.